The solution
For decades the federal government took title to inventions from the research it funded but lacked the means or motive to license them to product makers.
The 1980 Bayh-Dole Act let universities and small businesses own and exclusively license those patents, so a single institution had both the rights and the profit motive to pursue commercial use.
By the 2000s the act was widely credited with creating a university technology-transfer industry that turned lab results into biotech and other innovations.
What it achieved
Give the university the patent so it has a reason to license
Why it worked
Assigning the patent gave a university a financial reason to seek a licensee rather than file it away.
Exclusive licenses let a company invest in development without fear a rival would free-ride on the invention.
Royalties funded further research, and university licensing offices professionalised the transfer of inventions.
The same rights were offered to small businesses, spreading the benefit beyond large corporations.
What can be applied
Ownership is the incentive: assign the patent to the party best placed to commercialise it, and the research finds its own route to market.
Aftermath
University patenting and licensing grew rapidly after the law, and by the 2020s the Bayh-Dole Coalition attributed over $1 trillion to GDP, 6.5 million jobs and more than 17,000 start-ups to technology-transfer activity it enabled.
FOLLOW THE EVIDENCE
The sources
- Hearing on the Bayh-Dole Act and technology transfer govinfo.gov
- Unleashing America's Entrepreneurs: The Bayh-Dole Formula for Economic Prosperity bayhdolecoalition.org